B Cell Lymphoma Clinical Trials

ReadTheTrial indexes 1 studies for B Cell Lymphoma. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for B Cell Lymphoma.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials for B Cell Lymphoma

A Phase 1/2, Open-Label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD19 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX112) in Subjects With Relapsed or Refractory B Cell Malignancies

NCT05643742 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for B Cell Lymphoma?

There are 1 clinical trials listed for B Cell Lymphoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting B Cell Lymphoma trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are B Cell Lymphoma trials in?

Current B Cell Lymphoma trials are distributed across: Phase 2 (1).

Find More Trials